About Randox Life Sciences
Randox Life Sciences is a company based in Crumlin (United Kingdom) founded in 2005 by Peter Fitzgerald. It operates as a B2B. Randox Life Sciences offers products and services including Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, and Conjugates. Randox Life Sciences operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Crumlin, United Kingdom
- Founders Peter Fitzgerald
- SectorsHealthcare
- Website randox-lifesciences.com
- Social X Facebook
Products & Services of Randox Life Sciences
Randox Life Sciences offers a comprehensive portfolio of products and services, including Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, and Conjugates.
Antibodies used for targeted diagnostic and research applications.
Diverse antibodies for broad biochemical and assay uses.
Proteins manufactured for human health and research purposes.
Chemical compounds for linking antibodies in scientific tests.
People of Randox Life Sciences
1 people are tracked at Randox Life Sciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Peter Fitzgerald | Founder, Manager | Leadership |
Complete people profiles for Randox Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Randox Life Sciences
Randox Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | – | Monoclonal antibody technology and products are developed by Epitomics. | |
| ybiologics.com | 2007 | Daejeon, South Korea | $42.1M | – | Developer of antibodies for the treatment of multiple diseases | |
| mabtech.com | 1986 | Nacka, Sweden | – | – | Antibodies and immunoassay kits are developed for research applications. | |
| vectorlabs.com | 1976 | Burlingame, United States | – | – | Labeling and detection reagents immunohistochemistry studies and other life science research applications | |
| opmbiosciences.com | 2013 | Pudong, China | $14.42M | – | Antibody and vaccine culture media products are developed. | |
| itb-med.com | 2016 | Stockholm, Sweden | $87M | – | Monoclonal antibodies are developed to prevent transplant rejections. | |
| abrevbio.com | 2018 | Nanjing, China | $90M | – | Antibody-drug development platforms are provided for life sciences research. | |
| chromotek.com | 2008 | Planegg, Germany | $508,932 | – | Immunologic research tools for cell biology and proteomics are provided. |
Detailed competitors of Randox Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Randox Life Sciences
Websites that share an audience with Randox Life Sciences (randox-lifesciences.com).
Websites whose visitors overlap most with Randox Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fusionantibodies.com | 100% | – | – | View details | |
| mitosciences.com | 100% | – | – | View details | |
| immunochemistry.com | 98% | – | – | View details | |
| abnova.com | 96% | 30.7K | #957,320 | View details | |
| kpl.com | 94% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Randox Life Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Randox Life Sciences
10 companies that operate in the same segment as Randox Life Sciences (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Randox Life Sciences
Randox Life Sciences was founded in 2005.
Randox Life Sciences is headquartered in Crumlin, United Kingdom. It is registered at Crumlin, Northern Ireland, United Kingdom.
Randox Life Sciences has been developing and manufacturing a wide variety of antibodies, conjugates, and human recombinant proteins for over 30 years. The company offers products for assay development, custom manufacturing, and targets areas like drugs of abuse, steroids, and hormones. They provide services for purchasing single items or bulk supplies, catering to researchers and industries in life sciences.
Randox Life Sciences's top competitors include Sino Biological, GenScript and Y-Biologics.
Randox Life Sciences offers Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, and Conjugates.